{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "abstract": "Food and Drug Administration approves two new skin cancer drugs from Bristol-Myers Squibb; drugs Opdivo and Yervoy work by bolstering immune system.", "type_of_material": "Brief", "word_count": "138", "lead_paragraph": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "pub_date": "2015-10-02T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Approves Combining 2 Cancer-Fighting Drugs", "content_kicker": "Business Briefing", "print_headline": "Fda Approves Combining Two Cancer-Fighting Drugs ", "kicker": "Business Briefing"}, "snippet": "The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/10/02/business/fda-approves-combining-2-cancer-fighting-drugs.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Bristol Myers Squibb Company", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Skin Cancer", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Melanomas", "name": "subject"}], "blog": [], "_id": "560dcddc38f0d81aa77a5214", "source": "The New York Times"}